Physiomics Share News (PYC)
PYC Share
PYC Share
PYC Share
PYC Share
PYC
PYC Share
PYC Level 2
PYC Live
PYC Broker
PYC Directors
PYC Financial
PYC
PYC Short
PYC
Last checked at -
Thu, 12th Mar 2015 08:26
LONDON (Alliance News) - Physiomics PLC shares fell Thursday after it raised GBP270,000 in a discounted share placing, funds it will use for working capital.
The company said it issued 450 million new shares at 0.06 pence a share. Its shares were down 15% at 0.0678 pence early Thursday, making it one of the worst-performing stocks on the AIM All-Share index.
By Steve McGrath; stevemcgrath@alliancenews.com; @stevemcgrath1
Copyright 2015 Alliance News Limited. All Rights Reserved.
UK Shareholder Meetings Calendar - Next 7 Days
Read moreIN BRIEF: Physiomics Pens New Merck KGaA, Bicycle Therapeutics Deals
Read more
(Sharecast News) - Oncology consultancy Physiomics has been awarded further contracts of an undisclosed value for projects with existing clients Bicycle Therapeutics and Merck.
Read moreIN BRIEF: Physiomics Annual Revenue Grows And Loss Narrows
Read moreUK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic
Read more(Sharecast News) - Oncology consultancy Physiomics announced on Friday that it has been awarded a contract by a new client, Japan-based global pharmaceutical company Astellas Pharma.
Read moreIN BRIEF: Physiomics Has No Explanation For Share Price Surge
Read morePhysiomics Raises New Funds To "Further Develop Its Business"
Read more(Sharecast News) - Oncology consultancy Physiomics has raised roughly £829,000 through a share issue to finance further development.
Read morePhysiomics Secures Additional Contract With Bicycle Therapeutics
Read morePhysiomics Believes Strong Pipeline Can Withstand Covid-19 Oubtreak
Read more(Sharecast News) - Oncology consulting company Physiomics has received a 'Connect' award from the National Institute for Health Research's (NIHR) 'Invention for Innovation' (i4i) programme, for the continued development of its tool for use in the personalised treatment of cancer.
Read morePhysiomics Secures Contract Extension With Existing Client Merck
Read morePhysiomics First Half Revenue Rises But No Grants Means Widened Loss
Read more(Sharecast News) - Oncology consultancy Physiomics said on Tuesday that interim losses had widened despite posting an improvement in revenues.
Read more
Last checked at